These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34496300)

  • 1. Expulsion rates of the levonorgestrel 52 mg intrauterine system are similar among women with heavy menstrual bleeding and users for contraception.
    Furlani RM; Garcia E; Castro S; Machado HC; Bahamondes L; Monteiro I
    Contraception; 2022 Jan; 105():75-79. PubMed ID: 34496300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
    Modesto W; Bahamondes MV; Bahamondes L
    Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby A; Hussain M; Rishworth JR; Rees MC
    Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby AE; Cooke I; Rees M
    Cochrane Database Syst Rev; 2005 Oct; (4):CD002126. PubMed ID: 16235297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malposition and expulsion of the levonorgestrel intrauterine system among women with inherited bleeding disorders.
    Rimmer E; Jamieson MA; James P
    Haemophilia; 2013 Nov; 19(6):933-8. PubMed ID: 23711358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit-risk assessment of the levonorgestrel intrauterine system in contraception.
    Backman T
    Drug Saf; 2004; 27(15):1185-204. PubMed ID: 15588115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal intrauterine devices.
    Rybo G; Andersson K; Odlind V
    Ann Med; 1993 Apr; 25(2):143-7. PubMed ID: 8489751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for failure of the levonorgestrel releasing intrauterine system in women with heavy menstrual bleeding.
    Beelen P; van den Brink MJ; Herman MC; Geomini PM; Duijnhoven RG; Bongers MY
    BMC Womens Health; 2021 Feb; 21(1):57. PubMed ID: 33563257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
    Luukkainen T; Toivonen J
    Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resources and procedures in the treatment of heavy menstrual bleeding with the levonorgestrel-releasing intrauterine system (LNG-IUS) or hysterectomy in Brazil.
    Bahamondes MV; de Lima Y; Teich V; Bahamondes L; Monteiro I
    Contraception; 2012 Sep; 86(3):244-50. PubMed ID: 22459236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding pattern and user satisfaction in second consecutive levonorgestrel-releasing intrauterine system users: results of a prospective 5-year study.
    Heikinheimo O; Inki P; Schmelter T; Gemzell-Danielsson K
    Hum Reprod; 2014 Jun; 29(6):1182-8. PubMed ID: 24682613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.
    Suvisaari J; Lähteenmäki P
    Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of baseline bleeding pattern on amenorrhea with levonorgestrel intrauterine system use.
    Mejia M; McNicholas C; Madden T; Peipert JF
    Contraception; 2016 Nov; 94(5):556-560. PubMed ID: 27364099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of clinical experience with the frameless LNG-IUS for contraception and treatment of heavy menstrual bleeding.
    Wildemeersch D; Andrade A
    Gynecol Endocrinol; 2010 May; 26(5):383-9. PubMed ID: 20192899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine volume, menstrual patterns, and contraceptive outcomes in users of the levonorgestrel-releasing intrauterine system: A cohort study with a five-year follow-up.
    Magalhaes J; Ferreira-Filho ES; Soares-Junior JM; Baracat EC
    Eur J Obstet Gynecol Reprod Biol; 2022 Sep; 276():56-62. PubMed ID: 35809459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the Levonorgestrel Intrauterine System to Treat Heavy Menstrual Bleeding in Adolescents and Young Adults with Inherited Bleeding Disorders and Ehlers-Danlos Syndrome.
    Huguelet PS; Laurin JL; Thornhill D; Moyer G
    J Pediatr Adolesc Gynecol; 2022 Apr; 35(2):147-152.e1. PubMed ID: 34775059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefit-risk review.
    Kaunitz AM; Inki P
    Drugs; 2012 Jan; 72(2):193-215. PubMed ID: 22268392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One year quality of life measured with SEC-QoL in levonorgestrel 52 mg IUS users.
    Cristobal I; Lete LI; Viuda E; Perulero N; Arbat A; Canals I
    Contraception; 2016 Apr; 93(4):367-371. PubMed ID: 26764120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D; Schacht E
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.